Core Studies News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Older people, those with multimorbidity, and those with specific underlying health conditions remain at increased risk of COVID-19 hospitalisation and death after the initial vaccine booster and should, therefore, be prioritised for additional boosters, including novel optimised versions, and the increasing array of COVID-19 therapeutics.

Details about the COVID-19 National Core Studies (NCS) programme.

Doctors have a poor understanding of long COVID in children, report says The clinical definition of long COVID in children is at present very limited and poorly understood by doctors, according to a new report published today [21 July]. The report also found that symptoms typically associated with long COVID were having a significant physical and psychological impact on children's day-to-day lives. Long COVID is commonly used to describe signs and symptoms that continue or develop after acute COVID‑19. The report, led by the University of Bristol, is the first step in a COVID-19 testing in ...

A condition that affects the blood, known as idiopathic thrombocytopenic purpura (ITP), may be associated the Oxford-AstraZeneca vaccine in rare cases, research suggests.

Idiopathic thrombocytopenic purpura (ITP), a condition that affects the blood by low platelet count, may be associated the Oxford-AstraZeneca COVID vaccine in rare cases.